回顾 | 再出发，Arab Health 2025参展圆满成功

在龙年除夕夜、蛇年新春万家灯火之际，瑞桥鼎科集团国际业务团队再次携集团旗下三大业务线最新产品亮相迪拜举行的第50届阿拉伯国际医疗器械展览会（Arab Health 2025）。作为全球及中东地区医疗器械领域的标志性盛会，本届展会吸引了来自全球180多个国家、约3800家参展商，以及超过60000名相关专业从业人员共襄盛举，交流前沿。

On the eve of the Lunar New Year, as families around the world celebrated the transition from the Year of the Dragon to the Year of the Snake, EverBridge Group's international team made its second appearance at Arab Health in Dubai, showcasing the latest products in peripheral intervention, neurointervention, and oncology. Marking its 50th anniversary in 2025, Arab Health is one of the most significant medical equipment exhibitions in the Middle East and globally. This year's event attracted approximately 3,800 exhibitors from over 180 countries and more than 60,000 professional visitors.

瑞桥鼎科集团在此次展会上接待了众多国内外从业者，展示了外周血管、神经科学及肿瘤诊疗一体化等多款创新产品，包括行业领先的外周锥形球囊、搭载先进射频消融技术的外周治疗设备，以及最新上市的神经导管及外周导丝。

As a leading Chinese medical technology enterprise, EverBridge Group presented a range of innovative products at the exhibition, including industry-leading peripheral tapered balloons, peripheral treatment devices equipped with advanced radiofrequency ablation technology, and newly launched neuro catheters and peripheral guidewires. These products drew significant attention from distributors worldwide, with some samples running out due to high demand.

此次参展的创新产品满足了不同临床需求，迅速吸引了各方广泛关注，更是对外周锥形球囊、导管等产品给予了高度及赞誉，表示出浓厚的合作意向。这为我们开辟海外新市场、加速全球化布局再次坚定了信心、夯实了基础。

During the exhibition, EverBridge Group's international team welcomed numerous clients at their booth, including existing partners from the previous year and many new connections. Clients expressed high recognition of our balloons, catheters, and other products, showing strong interest in collaboration. This participation not only strengthened relationships with existing partners but also laid a solid foundation for exploring new markets and expanding our global business.

瑞桥鼎科集团始终矢志不渝为全球慢病患者提供创新、高质、普惠的医疗科技解决方案。时刻关注全球市场对高质量医疗产品的迫切需求。未来，我们将继续以创新为驱动力，推动医疗科技的进步，为全球医疗健康事业的进步贡献力量。

EverBridge Group remains committed to providing innovative, high-quality, and accessible medical technology solutions to patients worldwide. Through this exhibition, we further demonstrated our technological capabilities and product advantages while gaining a deeper understanding of the global market's urgent demand for high-quality medical products. Moving forward, we will continue to drive innovation, advance medical technology, and contribute to global healthcare.